SELLAS Life Sciences Group, Inc. (SLS)

2.03 +0.02 (+1.00%) USD  |  NASDAQ  |  Dec 12, 16:00
2.05 +0.02 (+0.99%) After-Hours: 20:00
More

SELLAS Life Sciences Group EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Geron Corp. --
GT Biopharma, Inc. --
ADMA Biologics, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --